SNPS

Synopsys
D

SNPS

Arincen72/100B

Synopsys income statement 1990–2026

9.42B USD over the last twelve months, and 7.05B USD in fiscal year 2025.

Revenue Operating income Net income

Click a line's chart icon in the table to add it to the chart; hover over it for a quick look.

Fiscal year
TTM
31 Jul 2026
FY2025
31 Oct 2025
FY2024
31 Oct 2024
FY2023
31 Oct 2023
FY2022
31 Oct 2022
FY2021
31 Oct 2021
FY2020
31 Oct 2020
FY2019
31 Oct 2019
FY2018
31 Oct 2018
FY2017
31 Oct 2017
FY2016
31 Oct 2016
Revenue
9.42B7.05B6.13B5.32B4.62B4.20B3.69B3.36B3.12B2.72B2.42B
Revenue growth
+46.33%+15.12%+15.22%+15.22%+9.79%+14.08%+9.66%+7.68%+14.54%+12.48%+8.04%
Cost of revenue
2.60B1.62B1.25B1.03B898.01M861.78M794.69M752.95M735.90M654.18M542.96M
Gross profit
6.82B5.43B4.88B4.29B3.72B3.34B2.89B2.61B2.39B2.07B1.88B
Gross margin
72.38%76.98%79.68%80.62%80.54%79.50%78.44%77.60%76.42%75.99%77.59%
Research and development
2.88B2.48B2.08B1.85B1.59B1.50B1.28B1.14B1.08B908.84M856.71M
Selling, general and administrative
2.27B1.84B1.43B1.10B956.28M1.04B915.94M862.11M885.54M746.09M668.33M
Operating expenses
5.90B4.52B3.53B3.01B2.57B2.61B2.27B2.09B2.02B1.72B1.56B
918.25M914.93M1.36B1.27B1.15B734.79M620.14M520.23M360.23M347.56M317.40M
Operating income growth
-16.85%-32.51%+6.48%+10.84%+56.33%+18.49%+19.20%+44.42%+3.64%+9.50%+19.11%
Operating margin
9.75%12.97%22.13%23.94%24.89%17.48%16.83%15.48%11.54%12.76%13.10%
Interest income
69.49M277.68M67.02M36.67M—74.05M3.56M6.86M5.32M7.24M3.72M
Interest expense
624.07M446.73M36.83M2.70M1.70M3.37M5.14M11.66M15.61M7.30M3.77M
Other non-operating income
380.53M478.22M158.15M32.23M-45.26M70.72M18.02M25.28M3.32M35.54M12.15M
Pretax income
1.30B1.39B1.51B1.31B1.10B805.51M638.16M545.51M363.54M383.10M329.55M
Income tax
223.03M55.99M99.72M90.19M139.39M49.16M-25.29M13.14M-68.98M246.54M62.72M
Effective tax rate
17.17%4.02%6.59%6.91%12.63%6.10%-3.96%2.41%-18.97%64.35%19.03%
1.08B1.33B2.26B1.23B984.59M757.52M664.35M532.37M432.52M136.56M266.83M
Net income growth
-46.12%-41.14%+84.03%+24.91%+29.98%+14.02%+24.79%+23.09%+216.72%-48.82%+18.10%
Net margin
11.43%18.89%36.94%23.13%21.33%18.02%18.03%15.84%13.86%5.01%11.01%
Basic shares
175.60M160.17M153.14M152.15M153.00M152.70M151.14M149.87M149.04M150.46M152.02M
Diluted shares
176.82M161.68M155.94M155.20M156.49M157.34M155.71M154.19M153.39M154.87M154.72M
Change in diluted shares
+12.27%+3.68%+0.48%-0.82%-0.54%+1.05%+0.98%+0.52%-0.96%+0.10%-2.12%
EPS (basic)
5.768.1314.788.086.444.964.403.552.900.911.76
EPS (diluted)
5.728.0414.517.926.294.814.273.452.820.881.73
EPS growth
-55.22%-44.59%+83.21%+25.91%+30.77%+12.65%+23.77%+22.34%+220.45%-49.13%+20.98%
EBITDA
3.73B2.50B1.85B1.56B1.33B1.01B853.29M758.84M588.36M579.84M540.35M
EBITDA margin
39.65%35.44%30.12%29.25%28.89%24.08%23.15%22.58%18.85%21.28%22.31%
EBIT
1.92B1.84B1.55B1.31B1.11B808.88M643.30M557.17M379.15M390.40M333.32M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

Common questions about Synopsys's income statement

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.